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Abstract 
 
An accurate characterisation of nanomaterials used in clinical diagnosis and 
therapeutics is of paramount importance to realise the full potential of 
nanotechnology in medicine and to avoid unexpected and potentially harmful toxic 
effects due to these materials. A number of technical modalities are currently in use 
to study the physical, chemical and biological properties of nanomaterials but they all 
have advantages and disadvantages. In this review, we discuss the potential of a 
relative newcomer, Tunable Resistive Pulse Sensing (TRPS), for the 
characterisation of nanomaterials and its applications in nanodiagnostics.   
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Introduction 
 
Nanomedicine, a branch of Nanotechnology, despite it being a relatively new 
discipline, has already shown great promise in the areas of in-vitro medical 
diagnostics, in-vivo imaging, regenerative medicine, drug development and delivery 
[1-3]. The unique properties of nanomaterials (size, high surface to volume ratio, 
surface characteristics and functionality) make them ideally suited for biosensors and 
for targeted drug delivery. The size of the nanomaterial gives a distinct advantage in 
that a drug could be transported across physiological barriers such as blood brain 
barrier. Furthermore, the relative ease by which nanomaterials could be linked with 
various biomolecules such as antibodies or ligands, to precisely target and deliver a 
drug to a particular organ or tissue is a major advantage of this technology. Such 
precise targeting can greatly reduce systemic toxicity. Another unique feature of this 
technology is that a nanopharmaceutical could be constructed to carry not only a 
drug but also a sensor to enable visualisation of the diseased tissue by imaging and 
also achieving targeted delivery of a drug.  This combined therapeutic and diagnostic  
application (dubbed 'Theranostics') is fast becoming a reality. 
 
It must, however, be emphasised that despite the great potential of nanomaterials in 
medicine, in order to realise their full potential, they must be fully characterised [4]. 
The size, shape and surface charge of the nanomaterials must be accurately 
analysed. In addition, detailed evaluation to study the fate of nanopharmaceuticals 
following systemic administration must be carried out. These evaluations must 
include stability of the nanomaterial in body fluids and tissues i.e. whether they 
undergo any disintegration in biological fluids that may result in significant change to 
their properties. Conversely the nanomaterial may coalesce to form larger particles 
with different properties or form aggregates with altered functions. In addition, 
detailed analysis into how nanopharmaceuticals interact with the components of 
body fluids such as blood must be carried out. In particular, the interaction with 
various plasma proteins, lipids and other biomolecules, change in the surface charge 
(zeta potential) and the 'corona' effect must be studied. Methods to study interaction 
of nanopharmaceuticals with various blood cells to find out whether they passively 
adsorb onto cells or actively bind to a cell surface due to upregulation of various 
cellular adhesion molecules, whether the nanomaterial causes significant activation 
of any cell (eg. neutrophils, monocytes, lymphocytes, platelets and vascular 
endothelial cells) and whether the nanomaterial causes any cell membrane damage 
resulting in increased permeability or cell lysis must be established. 
 
There is a range of techniques that are being used to study the physico-chemical 
characteristics of various nanomaterials (Box 1). They all have advantages and 
disadvantages and not a single technique that will be able provide all the information 
required exists. A recent addition to this diagnostic array is Tunable Resistive Pulse 
Sensing which is a variant of the much established technology of Resistive Pulse 
Sensing (RPS).  
 Analytic techniques for characterisation of nanomaterials 
 
Microscopy 
 High resolution Optical Microscope 
 Confocal Microscope 
 Multiphoton Microscope 
 4Pi Microscope 
 Cyto Viva Microscope  
 Magnetic Resonance Force Microscope (MRFM) 
 Fluorescence Microscope 
 Scanning Electron Microscope (SEM) 
 Transmission Electron Microscope (TEM) 
 Freeze Fracture Transmission Electron Microscope (ffTEM) 
 Scanning Tunnelling Microscope (STM) 
 Atomic Force Microscope (AFM) 
 Scanning Near-Field Optical Microscope (SNOM) 
 
Resistive Pulse Sensing 
 High-resolution flow cytometry 
 
Diffraction techniques 
 X-ray Defraction 
 Electron Defraction 
 Neutron Defraction 
 Small Angle X ray Scattering (SAXS) 
 Small Angle Neutron Scattering (SANS) 
 Dynamic Light Scattering (DLS) 
 
Nanoparticle Tracking Analysis (NTA) 
  
Spectroscopy 
 Optical absorption spectrometer 
 UV spectrometer 
 Infrared spectrometer 
 Dispersive infrared spectrometer 
 Fourier transform infrared spectrometer 
 Raman spectroscopy 
 UV photoelectron spectroscopy 
 Auger electron spectroscopy 
 
Magnetic measurements 
 Vibrating sample magnetometer (VSM) 
 
Box 1. Analytic techniques for characterisation of nanoparticles. 
(Source: Kulkarni SK [5], Jain KK [2]) 
Resistive Pulse Sensing 
 
The technique of resistive pulse sensing (RPS) to enumerate particles in solution 
was first developed by Wallace. H. Coulter in early 1950s [6]. The principle of this 
technique is that when a particle traverses through a channel filled with aqueous 
electrolyte solution, there is a transient change in the channel's ionic resistance 
known as a 'resistive pulse'. As envisioned by Coulter, this technology was soon 
adopted for rapid counting of particles in biological fluids in particular in the field of 
Haematology where it is extensively used for enumeration of blood cells. 
Subsequently, in the 1970s, this technique was adapted for counting microorganisms 
including viruses and bacteriophages by de Blois and colleagues [7]. They were able 
to accurately size several type C oncorna viruses and T2 bacteriophages with a 
detection limit of 5x107 viruses per ml. 
 
A landmark development of a method to detect single stranded DNA using biological 
alpha-haemolysin pore by Kasianowicz et al in 1996 [8] with a promising potential of 
DNA sequencing reignited interest in resistive pulse sensing technology. This 
development together with the on-going rapid growth in nanotechnology based 
research and applications resulted in the resurgence of RPS based techniques for 
particle characterisation [9-11]. 
 
A variety of materials including carbon nanotubes [9], polydimethylsiloxane (PDMS) 
(Saleh OA & Sohn LL, 2002), glass (Lan et al, 2011], silicon [12] and polycarbonate 
(Sexton LT et al, 2007; Lee et al, 2004) have been used in RPS devices. 
One of the major attributes of the RPS technology is its ability to provide valuable 
information on individual particles within their environment [12-13]. Hence, this 
technology has been used to study a variety of parameters including concentration, 
size, charge and conductivity of diverse type of  particles, naturally occurring such as 
peptides, proteins, nucleic acids, cell derived particles (exosomes) and biomolecular 
complexes or man-made organic or inorganic nanomaterials, in different situations 
with exquisite resolution [9, 11-12, 14-16]. 
 
 
Tunable Resistive Pulse Sensing (TRPS) 
 
TRPS is an adaptation of RPS in which utilises a conical tunable elastomeric pore 
that can be stretched or relaxed to change the pore size to suit the sample [11, 13, 
15-19]. Tunable pore membranes are made of thermoplastic polyurethane and the 
pores are introduced by mechanical puncture. The concept of tunable nanopore 
membrane was first developed by Sowerby [20]. The membrane can be stretched in 
a biaxial direction to alter the pore size. The size of the pore can be altered as much 
as an order of magnitude [17]. 
 
 
Principle of Tunable Resistive Pulse Sensing 
 
The instrument associated with TRPS is produced by the company Izon Science, 
and as with standard RPS equipment two fluid reservoirs are to be filled with a 
conducting electrolyte solution. In the setup the pore is mounted horizontally and 
reservoirs oriented above and below the pore membrane, with the sample typically 
placed into the top reservoir, see figure 1.  
 
 
 
Figure 1 A. Sectional schematic of a pore. The sample is typically placed into the 
upper fluid cell. B. Example of baseline current and “blockade” events (current dips) 
that are each caused by an analyte traversing the pore. Each event is analysed for 
full width half maximum (FWHM) duration and Δip. C. The Izon qNano instrument, 
showing the fluid cell and location of crucifix plastic membrane. 
 
 
Applications of Tunable Resistive Pulse Sensing 
 
TRPS technology has a number of merits. The pore tunability offers flexibility in 
analysing particles of broad size range (40nm-10um). It enables particle by particle 
measurement of size and surface charge of individual particles simultaneously. it can 
also analyse particle aggregation and stability. It works with physiological strength 
buffers, provides high resolution data points, large number of data points and 
requires no software-induced data manipulation. It is relatively inexpensive off the 
shelf instrument requiring a few consumables and not needing carrier gases, fluidics 
or optics. 
 
 
TRPS in Nanoparticle Counting 
 
As particles/analytes translocate the pore they temporarily occlude ions, leading to a 
transient decrease in current known as a “blockade event”, examples of which can 
be seen in figure 1b. The pulse frequency, J, is related to the concentration of the 
analyte, Cs, multiplied by the velocity of the traversing particle, vp (ignoring 
contributions from diffusion). The velocity term is the sum of the fluidic, vF, 
electrophoretic, vE, and electroosmotic, vO, velocities, i.e. vp = vF + vE + vO. Here we 
typically ignore the contribution from diffusion due to the magnitude of other forces 
and end effects are not taken into account in the analysis. vp can be written as; 
 
                (1) 
Where         (1a) 
 and   are the permittivity of the solution and kinematic viscosity respectively, P 
is the pressure across the pore, pore and particle  are the zeta potential of the 
channel surface and particle respectively, and E is the electric field.  
 
TRPS in Nanoparticle Size Analysis 
 
The pores in the TRPS system are conical in shape and give rise to an asymmetric 
current pulse, figure 1b [21]. For a conical pore, the change in the resistance, ΔR, 
across the length of the pore. L, is given by equation 2 [22].  
 
                                                              (2) 
where ρ is the resistivity of the electrolyte that is filling the pore, A(z) is the cross 
sectional area perpendicular to the pore axis z and R is the pore resistance. When 
no blockage is present, R is given by equation 2,<sup>1</sup> 
   (3) 
Where DL and DS are the largest and small pore diameters. When a particle traverses 
through the pore, a blockade event is observed. This blockade is created by the 
particle displacing a volume of electrolyte which in turn increases the resistance in 
the circuit, temporarily lowering the current. The blockade magnitude can then be 
used to size the particles or analyte as the magnitude of the increased resistance is 
directly related to the size of the analyte.  
 
It must be noted that, unlike solid state pores where the size of the pore is always 
known, the tunable pore must first be characterised before users can accurately 
determine the size of the analyte using TRPS. This is done easily using calibration 
beads of a known size with a narrow size distribution amongst a sample population, 
and must be done prior to sample analysis and under the same conditions. 
 
A number of different techniques are available for the measurement of nanoparticle 
size (Box 1). Some of which (dynamic light scattering (DLS), small angle X ray 
scattering (SAXS) and static light scattering (SLS)) are termed 'Batch Particle Size 
Measurement methods because they perform size dispersion analysis of particles on 
the whole population ('batch'). On the other hand, techniques such as microscopy 
including electron and atomic force microscopies, Nanoparticle Tracking Analysis 
(NTA) and TRPS carry out single particle by particle measurement and are 
collectively called Single Particle Size Measurement methods. In a recent study, 
Varenne and co-workers (ref) evaluated nine different techniques in carrying out 
particle size distribution (PSD) of multimodal dispersion of nanoparticles. Their study 
showed that while single particle size measurement methods accurately determined 
the PSD, none of the batch particle size measurement methods was able to 
characaterise the complex PSD (Figure 2) 
 
 
 
 
Figure 2. Summary of the obtained PSD from the dispersion of PIBCA nanoparticles 
analyzed by different size measurement methods. Results from measurements 
performed with single size measurement methods (AFM, TRPS, NTA) and methods 
based on a separative process (AsFlFFF) are shown on the upper part of the graph. 
Results from measurements performed with batch size measurement methods 
comprising different light scattering methods (SLS, DLS, PCCS) are summarized on 
the lower part of the graph. * indicates a significant variation of the size position of 
the corresponding detected population. Mean diameters were calculated from the 
diameters of the population of nanoparticles with the corresponding size that was 
detected in a ± 5% range (shown by the grey background) by at least 3 different 
methods. Reprinted with permission from Pherm. Res (2016), 33: 1220-1234. 
Copyright Springer Science Business Media New York 2016 
 
TRPS in analysis of shape and two/three dimensional geometric structures of 
nanoparticles 
 
The majority of the work published to date has focused on spherical analytes or 
particles. Some initial studies by Willmott and Platt [18] have shown that some 
information of length of asymmetric particles (cylinders) or clusters of spherical 
particles can be extracted from peak width/ pulse duration. Other groups have also 
used the flexible TRPS pore to deform and characterise soft polymer like particles 
[23].  
 
 
 
TRPS in analysis of particle aggregation 
 
Analysis of particle aggregation forms the basis of a number of diagnostic platforms 
including biosensors and point of care devices. TRPS has been used successfully in 
the detection of very low concentrations of analytes because of its ability to detect 
and enumerate particle aggregates that are formed as a result of binding between 
the functionalised nanoparticles and the analyte. Examples of studies in which TRPS 
has been used to detect nanoparticle aggregation are given in Table 1. 
 
 
Particle 
material 
Particle size (nm) Surface function Analyte Analyte 
concentration 
Reference 
Au/Ni rods 1230 long x 
300 diameter 
1100 long x 
300 diameter 
 
Avidin (Ni) and  
PEG (Au) 
 
Aptamer (Ni) and  
PEG (Au) 
Biotin 
 
PDGF 
~ 100 fM 
 
~ 100fM 
67 
SPBs 3000 
1000 
300 
 
Avidin 
Avidin 
Streptavidin 
Biotin 
Biotin 
Biotin  
~ 1pM - 1nM 
~1 nM 
~1 nM 
68 
Au 25 
 
DNA DNA ~5 pM 69 
Au 50 
 
Citrate PNA ~5 nM 73 
Au 30 
35 
 
Avidin 
DNA 
DNA 530 copies 98 
Magnetic 
beads 
1000 Protein RBCs ~107 per ml 99 
 
Table 1. Particle aggregation studies using TRPS.   
PEG = polyethylene glycol, PDGF = platelet derived growth factor, PNA = peptide 
nucleic acid, SPBs = superparamagnetic beads, RBCs = red blood cells. Adapted 
from Weatherall & Willmott, Analyst, 140, 3318-3334 (2015). [ref] 
 
TRPS in nanoparticle surface charge analysis 
 
Evident from equation 3 is the relationship between particle velocity and its zeta 
potential.  Zeta potential is defined as the electrostatic potential at the border 
between the diffuse layer and compact layer<sup>2</sup> or Stern layer [24] of a 
colloidal system. Zeta potential is relative to surface charge of particles in 
suspension and is often used as an indicator of colloidal stability.  The Smoluchowski 
approach supports that a particle’s zeta potential can be determined from its velocity 
taking into account convective and electro osmotic forces, as well as the 
electrophoretic mobility of the particle. The electrophoretic mobility is a measure of 
the translocation time of the analyte through the pore under an applied electric field. 
In their seminal paper Vogel and Willmott [25] developed a method of balancing the 
electro osmotic and electrophoretic effects by balancing the pressure across the 
pore allowing zeta potential values to be extracted from the resistive pulse. In a later 
publication Blundell et al [26], used a similar concept that was published by Arjmandi 
et al [27] using pyramidal pores. Where a calibration based zeta potential method 
was applied, based on the measurement of signal durations of translocation events 
as a function of voltage. The electrophoretic mobility is calculated from the derivative 
of medium particle velocity and applied electric field.  
 
Sikora and co-workers investigated the effects of adsorbed proteins from serum on 
the size and surface charge of plain and aminated silica nanoparticles. The zeta 
potential was measured by electrophoretic light scattering (ELS) and TRPS (ref). 
They reported that the particle-by-particle ζ-potential measurements by TRPS were 
consistent with those performed with ELS and allowed a description of the ζ-potential 
distribution within the samples 
 
TRPS in analysis of nanoparticle interaction with biomolecules 
 
In biological fluids such as blood, the nanoparticles interact with the various 
constituents such as cells and plasma proteins, potentially changing the particle 
characteristics. Proteins in blood bind to the surface of nanoparticles to form a 
coating known as protein corona which can affect the interaction of nanoparticles 
with the biomolecules [28-29]. The protein corona formation can affect the kinetics 
and dynamics of the nanoparticle in biological fluids thus modifying the 
pharmacokinetics of nanopharmaceuticals. It is, therefore, imperative to study this 
phenomenon in detail.   
 
Blundell and co-workers [30] studied the effects of plasma proteins albumin, 
fibrinogen and immunoglobulins on nanoparticle-protein corona formation using 
100nm silica nanoparticles and TRPS. Their study showed that TRPS could monitor 
the kinetics of the protein corona forming on a particle and in particular what this 
effect then has on a nanoparticle's surface charge. The study also has shown that all 
three proteins had an effect on nanoparticle mobility through the pore, indicating that 
they are each forming protein-nanoparticle interactions. The researchers then went 
on to study the effects of plasma proteins on protein corona dynamics by studying 
changes in the zeta potential by TRPS [26]. TRPS promises to be a valuable tool to 
investigate this phenomenon of protein corona formation and its effect on 
nanoparticle kinetics in fluids, and other work by Shard et.al (ref) has compared the 
TRPS system with DLS for corona formation, shown in figure 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Normalized number-weighted particle size distributions of plain (A and C) and 
aminated (B and D) silica NPs in Tris (A and B) and serum-based (C and D) medium after 24 
h incubation measured by DLS, DCS, and TRPS. DCS measurements are plotted assuming 
a densities of 2.0 and 1.125 g/cm3 for the silica and the protein layers, respectively. 
Reprinted with permission from Langmuir  2016, 32, 2216-2224. Copyright © 2016 American 
Chemical Society [ref] 
 
 
 
TRPS in the analysis of nanoparticle-bound DNA interactions with 
biomolecules 
Particle bound oligonucleotides are incorporated into many assay platforms for DNA 
sequencing, study of DNA-protein interactions, biosensing and drug delivery [31]. 
Over the last few years TRPS has been used to study the interactions between 
nanoparticle-bound DNA and various biomolecules by detecting changes in the 
particle size or surface charge due to the binding of the biomolecules to the DNA or 
formation of aggregates [32]. 
Initially TRPS was used to identify binding of a 16nm long, 48 kbp double stranded 
DNA to silica nanoparticles by studying the changes in the surface charge [13]. DNA 
binding resulted in a reduction of surface charge without any discernible change in 
size. Subsequently, Booth et al [33] studied specific interaction between a 23 bp 
DNA fragment that was functionalised onto carboxylated dextran based magnetic 
particles, to its complementary target using TRPS. The hybridization of the particle 
bound DNA to its target sequence caused an increase in the surface charge as 
indicated by a rise in zeta potential.  
Single Nucleotide Polymorphism (SNP) analysis forms a basis of clinical diagnosis 
and disease monitoring in certain diseases. An example is G487A mutation in 
glucose 6 phosphate dehydrogenase (G6PD) deficiency that causes haemolytic 
anaemias. Ang and Yung [34] has developed a label-free detection method to rapidly 
identify single base pair mismatch in G6PD deficiency. They used two sets of 25nm 
gold particles with two different sized (18 and 100bp length) single stranded DNA 
fragments that are complementary to the different ends of a target attached onto 
them. Hybridization of the particle bound DNA with the target sequence formed 
different sized aggregates (dimers, trimers, tetramers and pentamers), shown in 
figure 3. These aggregates produced different sized pulses on TRPS. The sensitivity 
of this assay in detecting target DNA was between 5.0pM to 2.5nM and a result 
could be produced in 30 minutes. 
 
Figure 3 Schematic illustration of nanopore-based single-nucleotide detection using 
a nAu-DNA probe. The ssDNA sequences on nAu-100b and nAu-18b probes were 
designed to be complementary to the mutant (mut) sequence and single mismatched 
to the wild-type (wt) sequence. In the presence of a perfectly matched (PM) target, a 
well-defined nanoparticle assembly, termed conjugate grouping, forms. Each distinct 
conjugate grouping is picked up as an individual signal (“Yes” signal) when it 
translocates the pore of the membrane from the trans to the cis side. Every 
successful translocation activity is termed a blockade event, which is characterized 
by its blockade magnitude (Δi) and baseline translocation duration (Δt). When a 
single-mismatched (SM) target is added, the intermediate duplex structure is 
energetically unstable and fails to form an assembly structure. The smaller-sized 
nAu-DNA probe does not result in an appreciable dip in baseline current (ic) and is 
taken to produce a “No” signal. Reprinted with permission from ACS Nano, 2012, 6, 
pp 8815–8823. Copyright (2012) American Chemical Society. [ref] 
 
Yang et al [35] has reported a novel diagnostic assay for detection of the Panton-
Valentine leukocidin (PVL) DNA from methicillin-resistant Staphylococcus aureus 
(MRSA) using TRPS and loop-mediated isothermal DNA amplification (LAMP) in 
combination with gold nanoparticles.  The researchers first amplified the PVL DNA 
from MRSA by LAMP using four primers. The amplified DNA was conjugated to gold 
nanoparticles of two different sizes (55 and 30 nm respectively) to generate dual 
gold nanoparticle assemblies. The detection and quantification of the agglomerated 
gold nanoparticles were performed by TRPS.  The researchers concluded that this 
technique is capable of detecting 500 copies of genomic DNA from the bacteria 
MRSA MW2 and the detection can be completed within two hours with a signal-to-
readout setup providing a valuable tool for MRSA detection in clinical laboratory 
setting. 
Kuhnemund and Nilsson [36] employed rolling circle amplification technique (RCA) 
to amplify the target DNA and TRPS to carry out label free detection of DNA 
products on magnetic particles. The target DNA molecules were detected by padlock 
probes which were circularised by ligase reaction. The DNA-padlock probe complex 
was captured on magnetic particles by sequence specific oligonucleotides and 
amplified by RCA. TRPS was used to detect individual particles with amplified DNA 
product. The lower detection limit of this technique was 1fM with an assay time of 
under one hour.  
More recently, Blundell et al [37] studied the changes in zeta potential of DNA 
modified particles using TRPS. The high sensitivity of TRPS enabled them to resolve 
the signals for single stranded and double stranded DNA fragments and detect small 
changes in base length for oligonucleotides between 15 and 40 bases long and 
discriminate between partial and fully complementary target sequences. The authors 
note that this technique has a potential application in sensors for monitoring 
nanoparticles in medical and environmental samples. 
 
TRPS in the analysis of nanoparticle bound aptamer interactions with 
biomolecules 
 
Aptamers are short single-stranded pieces of DNA or RNA capable of binding to 
analytes with specificity and high affinity. Aptamers are generated through the 
process of SELEX (Systematic Evolution of Ligands by Exponential Enrichment) [38-
39] or by CLADE (Closed Loop Aptameric Directed Evolution) [40]. More recent 
technologies to incorporate aptamers as the target capture probe are Resistive Pulse 
Sensing [41] and its variant technology Tunable Resistive Pulse Sensing [42]. Rotem 
and colleagues [41] attached an aptamer for thrombin to ἀ-haemolysin nanopore and 
observed the interaction between the aptamer and its target molecule thrombin by 
RPS. Using this approach, they were able to detect the target molecule at nanomolar 
concentration. Platt and colleagues [42] were the first to utilise TRPS technology to 
study interactions between nanoparticle-bound aptamers and target molecules. They 
employed a different strategy using an aptamer for platelet derived growth factor 
(PDGF) tagged on to cylindrical nanorods containing gold and nickel segments. 
Each rod was a 'bar code'.  They used TRPS to study the interaction between the 
aptamer and the target molecule and observed that the pulse magnitude and FWHM 
were specific to a particular shape of the resulting aggregate. They were able to 
detect the target molecule at femtomolar concentrations.  
 
Following on from this work, Billinge and Platt have developed a multiplexed, label-
free platform using aptamers and TRPS (AptaTRPS) for the detection of biomarkers 
[43]. The researchers tagged aptamers to vascular endothelial growth factor (VEGF) 
and platelet derived growth factor (PDGF) on to 120nm and 300nm streptavidin 
modified superparamagnetic beads respectively, shown in figure 4. The binding of 
the target molecules to the aptamers was analysed by TRPS. Interestingly, they 
were able to observe binding of two proteins to their specific aptamers 
simultaneously.  
 
 
 
 
Figure 4: A bar graph comparing the average particle rates of 120 nm beads functionalised 
with V7t1 as VEGF165 concentration increases with or without the addition of 10 nM PDGF-
BB in the presence of 300 nm beads functionalised with anti-PDGF aptamer. B bar graph 
comparing the average particle rates of 300 nm beads functionalised with anti-PDGF 
aptamer as PDGF-BB concentration increases with or without the addition of 10 nM VEGF165 
in the presence of 120 nm beads functionalised with V7t1. C 3D surface plot displaying the 
effect of PDGF and VEGF on particle rate of 120 nm beads. D 3D surface plot displaying the 
effect of PDGF and VEGF on particle rate of 300 nm beads.Reprinted with permission from 
Biosensors and Bioelectronics, Volume 68, 2015, 741–748. [ref] 
 
 
 
 
 
 
 
 
Alsager and co-workers [44] have designed a simple sensor to detect 17β-estradiol 
utilising an aptamer attached to the surface of 217nm sized carboxylated polystyrene 
nanoparticles. The interactions between the aptamer conjugated nanoparticle and 
the target molecule were studied by TRPS and DLS. Resistive pulse sizes increased 
with the attachment of the aptamer. Binding of the target to the aptamer resulted  in 
decrease in the pulse size due to conformational change. The detection limit of this 
sensor system was reported to be in the lower nanomolar range. 
  
 
TRPS in extracellular vesicles analysis 
 
Extracellular vesicles (EVs) are lipid bilayer membrane vesicles secreted by most 
living cells. The generation and release of EVs from living cells is a physiological 
process that occurs during cell growth and activation without affecting cell viability 
[45-46]. Extracellular vesicles (ECVs) are generated either at the plasma membrane 
(microvesicles) or within endosomal structures (exosomes). ECVs are very 
heterogeneous varying greatly in size and content. They vary in size from 20nm in 
diameter to 1000nm. The small ECVs (20-100nm) comprise the more homogenous 
population of exosomes and the larger vesicles (100-1000nm), referred to as 
microvesicles, originate from plasma membrane. Physiologically EVs play a role in 
inter-cellular communications, immune responses, coagulation, inflammation,  
transport, cellular homeostasis and survival. The concentration and composition of 
the EVs can be altered in pathological states. The EVs can carry microRNA and 
have been shown to promote tumour invasiveness and metastasis and can confer 
resistance to drugs and promote endothelial cell migration, invasion and 
neovascularization acting as carriers of angiogenic stimuli. 
Over the last few decades, there has been an intense interest in studying EVs in 
order to understand their role in physiology and various pathological states including 
cancer, inflammatory states and neurodegenerative diseases and to explore their 
potential as early diagnostic and prognostic markers . Furthermore, EVs have also 
been explored as potential drug delivery vehicles [47]. As a result, there have been a 
surge in the number of diagnostic modalities to study EVs. Over the last few years, a 
number of studies have employed TRPS as a diagnostic tool to characterise EVs 
[48-52 ].  
de Vrij et al [48] investigated the ability of TRPS to quantify non-purified EVs in 
various body fluids including urine, blood plasma and pleural fluid and culture 
supernatants. They found that, in all the samples studied, more than 95% of particles 
were in the range of 150-400nm. Their study confirmed that TRPS is capable of 
measuring MVs in biological samples without the requirement of any prior MV 
isolation or labelling. The reproducibility of TRPS in determining the size and 
concentration of EVs was studied by Coumans et al [49]. They used beads and 
standard urine sample for their experiment with the instrument set at fixed stretch 
and voltage or fixed blockade height. Based on their findings, they concluded that 
pore to pore variability is the cause of the variation in minimum detected size when 
setting a fixed stretch and voltage. The reproducibility of the minimum detectable 
diameter was improved by setting a fixed blockade height. 
The size distribution of MVs in the urine and blood was also studied by Cheng et al 
[53-54]. They undertook a study to profile miRNA in various blood components and 
identify differences in profiles within peripheral blood compared to cell-free plasma or 
serum and EVs. The characterisation of EVs was performed by TRPS. Their analysis 
showed that the EVs isolated from urine provided a consistent source of miRNA for 
further analysis.  
Although a number of exosome isolation protocols are currently available, there is a 
significant variation in their performance. In a bid to optimise the isolation protocol for 
cell culture supernatant and human plasma, Lobb et al [55] has undertaken a 
comparative analysis of four exosome isolation techniques using TRPS and protein 
analysis. The results obtained from this study have enabled them to identify the 
current shortcomings in EV isolation methods and to propose a standardised method 
for EV isolation. 
TRPS has also been employed to evaluate the effectiveness of therapeutic 
procedures in lowering certain biological substances. Effectiveness of apheresis in 
removing EVs was studied by combining TRPS and flow cytometry by Connolly and 
colleagues [56]. Their results showed that while lipoprotein-apheresis reduces 
circulating microparticles in patients with familial hypercholesterolaemia (FC), the 
procedure non-selectively lowered annexin V positive CD41 positive platelet derived 
particles. In another study in which nanofiltration was employed to remove 
microparticles to reduce thrombogenecity of human plasma, nanoparticle removal 
was evaluated by TRPS, DLS, NTA and flow cytometry [57]. 
Maas and co-workers [58] adopted a strategy of using samples spiked with 
polystyrene beads of known size and concentration and TRPS to measure them in 
order to overcome the technical hurdles encountered when measuring EVs in 
biological fluids. Lane et al [50] studied the effects of various exosome isolation 
protocols on vesicle recovery and size distribution using TRPS and 100nm 
liposomes as a model system, shown in figure 5. They demonstrated that liposome 
size distribution and ζ-potential are comparable to those of extracted exosomes, 
making them an ideal model for comparison studies.  
 Figure 5, (A) DLS percent intensity by size (nm) for ExoSpin, Invitrogen, PureExo, Ultracentrifugation 
and Unprocessed control. (B) TRPS measurements with an NP150 pore of particle size distributions 
for ExoSpin (n = 1777), Invitrogen (n = 3302), PureExo (n = 0), Ultracentrifugation (n = 923) and 
unprocessed (n = 1312) samples respectively. Boxes indicate 25th, 50th and 75th percentile values, 
whiskers encapsulate 1st and 99th percentile values. (C) Modal ± SD particle diameter for ExoSpin (n 
= 3), Invitrogen (n = 3), ultracentrifugation (n = 3) treated samples and the unprocessed negative 
control as measured by TRPS with an NP150 pore. There was no significant difference in size 
between any of the processed samples and the unprocessed control (p>0.05). (D) Mean ± SD particle 
diameter for ExoSpin (n = 3), Invitrogen (n = 3), ultracentrifugation (n = 3) treated samples and the 
unprocessed negative control as measured by TRPS with an NP150 pore. There was no significant 
difference between any of the processed samples and the unprocessed control. Reprinted with 
permission from Scientific Reports (2015), 5, 7639. Copyright Nature Publishing Group [ref]. 
 
 
 
 
 
 
EVs derived from malignant cells including leukaemias and solid cancers are 
currently studied extensively. Analysis of tumour derived EVs may offer an early 
diagnostic and disease monitoring tool. Increasingly TRPS is being used to 
characterise tumour derived EVs. Boing et al [59] studied the role of the enzyme 
caspase-3 in inducing microvesicle release from breast cancer cells. In their 
transfection study using a caspase-3 deficient breast cancer cell line, the 
researchers demonstrated that caspase 3 transfected cells induced production of 
caspase-3 containing 400-600nm sized EVs. They characterised EVs using TRPS 
and flow cytometry. Their study showed that, compared to flow cytometry,  TRPS 
gave more relevant information about the size and size distribution of EVs.  
Mesenchymal cell derived EVs are being studied as potential drug delivery vesicles 
and gene vectors. Katsuda and co-workers [60] explored the potential of EVs as 
drug carrier for the treatment of Alzheimer's disease which is characterised by 
accumulation of beta-amyloid peptide in the brain. Beta amyloid is degraded by an 
enzyme neprilisin. The researchers isolated neprilysin containing EVs from  human 
adipose tissue-derived mesenchymal stem cells and characterised by TRPS and 
NTA. When the neprilisin expressing EVs were transferred into N2a cells, there was 
a reduction in the secreted and intracellular beta amyloid peptide. Shimbo et al [61] 
used a different strategy to obtain mesenchymal derived EVs containing synthetic 
miRNA (mRNA-143) for cancer therapy. They introduced the miRNA into cells and 
then collected the released EVs containing the synthetic RNA. They characterised 
the EVs by TRPS and transferred them to osteosarcoma cells. The transfer  of 
miRNA inhibited migration of osteosarcoma cells.  
It must be recognised that despite the availability of various technologies for the 
characterisation of EVs, there is considerable variation in the sensitivity and 
reproducibility between these diagnostic modalities as highlighted by the study of 
van der Pol [51]. The researchers measured the size and concentration of vesicles 
and reference beads with transmission electron microscopy (TEM), a conventional 
flow cytometer, a high resolution flow cytometer, nanoparticle tracking analysis 
(NTA), and resistive pulse sensing (RPS). Their study showed that each technique 
gave a different size distribution and a different concentration for the same vesicle 
sample. The researchers concluded that the differences between the detected 
vesicle concentrations are primarily caused by differences between the minimum 
detectable vesicle sizes. The importance of correct settings to obtain accurate and 
reproducible results were highlighted in the study undertaken by Mass et al [62]. 
They undertook a study to compare nanoparticle tracking analysis (NTA), high 
resolution flow cytometry and TRPS in quantifying EVs and 212nm sized synthetic 
liposomes. Their study showed that there were differences in absolute quantification 
of EVs and liposomes between the three technologies and highlighted the 
importance correct and standardised instrument settings to obtain accurate results. 
More recently, Akers et al [63] carried out a comparative analysis of technologies for 
quantifying extracellular vesicles (EVs) in cerebrospinal fluid of patients with 
glioblastoma. They compared the results obtained with TRPS, NTA, TEM and 
vesicle flow cytometry (VFC). Their results support the notion that the particle size 
does affect the quantitative analysis of EVs. For EVs <150nm in diameter, NTA 
detected more EVs than TRPS. For EVs >150nm diameter, NTA consistently 
detected lower number of EVs relative to TRPS. While TEM gave useful information 
about the morphology, it gave significantly lower counts compared to NTA and 
TRPS. The authors have suggested that a multiplatform quantitation will be required 
for clinical EV investigations.   
In order to address the issue of sensitivity and stability, Anderson et al [64] has 
carried out a comprehensive analysis of the parameters involved in TRPS exosome 
measurements and demonstrated the ability to improve system sensitivity and 
stability by the optimisation of parameters. They also provided the first analysis of 
the system noise, sensitivity cut-off limits, and accuracy with respect to exosome 
measurements and defined the system sensitivity. 
With the rapid expansion in extracellular vesicle research, it is anticipated that the 
utility of TRPS in characterising EVs will rise sharply over next few years. 
 
TRPS in Drug Delivery and Drug Development Applications 
 
As alluded in the Introduction, a variety of nanoparticles including liposomes, lipid 
complexes, polymers, nanocrystals, inorganic nanoparticles, dentrimers and several 
others are being explored as potential drug delivery vehicles. Some of them are 
already in clinical use (eg. liposomal amphotericin, nanocrystalised tacrolimus). It is 
known that the physical characteristics such as size, surface charge, concentration 
and composition can affect the pharmakokinetics, pharmacodynamics and 
toxicological properties of the nanoformulations [65]. 
 
Liposomes are the most commonly used nanoparticles for drug delivery. TRPS was 
first applied to characterise liposomes by Garza-Licudine and colleagues [66] to 
quantitate liposomes and polystyrene particles ranging from 200-400nm. They 
demonstrated that there was a linear relationship between the capture rate 
(translocation events per second) and applied pressure and membrane stretching 
distance. 
 
Yang et al [67] carried out a study to explore the application of scanning ion 
occlussion sensing (SIOS) as a novel technology for characterization of 
nanoparticles. The size distribution of the liposomes was measured by both SIOS 
and dynamic light scattering (DLS). The ability of SIOS and DLS to resolve bimodal 
samples was evaluated by measuring a mixture of 217 and 355 nm standard 
nanoparticles. The study showed that SIOS had higher sensitivity and better 
resolution than DLS in sizing bimodal particles. In addition, SIOS was able to detect 
opsonisation of liposomes by demonstrating an increase in the particle size and 
translocation rate. 
 
pH responsive polymeric expansile nanoparticles are novel drug delivery vehicles 
(eNP) that respond to acidic environments by swelling with water and expanding. 
Colby et al [23] used several techniques including electron microscopy, fluorescence 
microscopy and TRPS to measure particle size and concentration. The study 
showed that eNP occurs in a continuous manner. TRPS was able to monitor the size 
changes that took place over time. Resistive pulse sensing has also been employed 
to study hydrogels, another class of drug delivery nanoformulation [68]. 
 
Superparamagnetic iron oxide nanoparticles (SPIONs) are currently being explored 
for targeted photothermal therapy in cancer.  Upadhyay et al [69] investigated the 
potential of nanoformulation with SPION and a drug within a lipid matrix as a 
potentially targetable and thermosensitive inhalable drug delivery system. The 
therapeutic nanoparticle was characterised by TRPS. The formulations were found 
to be suitable for controlled delivery. The authors concluded that the system 
demonstrates promise as an effective drug vehicle in targeted and controlled 
inhalation therapy. The ability of TRPS to characterise SPIONs was also studied by 
Willmott and colleagues [18, 70]. SPIONS are widely used in molecular identification, 
purification, separation and aggregation. These are crucial steps in drug 
development. On the other hand, SPIONs are increasingly used for combined in-vivo 
imaging and cancer therapy (so-called theranostics). These findings may suggest 
that the TRPS technology may have an important role in drug development and 
theranostics.  
 
A number of techniques are used to characterise nanopharmaceuticals, but there is 
a lack of consistency and reproducibility among these technologies. In a bid to 
overcome these drawbacks and to satisfy the requirements of various regulatory 
agencies, Kozak and co-workers [72] carried out a comprehensive and high 
resolution analysis of liposomes. The simultaneous size and zeta potential analysis 
capabilities of TRPS enabled determination of the homogeneity and difference 
between unpegylated and pegylated liposomes. 
 
 
The role of TRPS in Microbiology 
 
The traditional methods employed to count microbes such as bacteria and viruses 
include microscopy (light or electron), plating and infectivity assay. These are 
laborious and time consuming. Hence, a rapid, simple and inexpensive method 
would be a great benefit to busy microbiology laboratories. In this respect, TRPS 
may offer a solution by providing an alternative diagnostic platform to count and size 
these microbes.  
 
As discussed in the earlier section, de Blois and colleagues [7] pioneered the use of 
resistive pulse sensing for quantitation and sizing of viruses as early as in 1977. But 
the potential of TRPS for this purpose was first explored by Willmott and colleagues 
[73] and Vogel and colleagues [15]. In the former study, TRPS was shown to be 
capable of detecting the unique shape (head and tail) of the lambda phage virus. 
Vogel et al used TRPS, TEM and DLS for quantitative sizing of synthetic 
(polystyrene) and biological (adenovirus) nanoparticles. It was shown that the 
calculated size of the adenovirus particle was in agreement with the results of TEM 
and DLS. Subsequently, Roberts and co-workers [19] used tunable pore technology 
to measure concentrations of Baculovirus. The determined concentrations agreed 
with those obtained from microscopic counting and flow cytometry.  
 
Arjmandi et al [74] used the technique to measure the mass of nanoparticles and 
viruses. They were able to measure the size and density of human 
immunodeficiency virus and Epstein-Barr virus. Using vesicular stomatitis virus 
(VSV) and 100nm polymer spheres as size controls, Akpinar & Yin [75] has shown 
that TRPS was able to quantify concentrations down to 107 particles per ml which 
was 50 fold lower than the detection limit of TEM. TRPS produced more reproducible 
counts than TEM. Furthermore, the total-to-infectious particle ratio of VSV 
populations as measured by TRPS and plaque assay has shown that each VSV 
particle was infectious. In addition, TRPS provided useful information about the 
particle size distributions based on hundreds of particles. 
 
TRPS has also been explored as a tool to measure concentration and size of 
bacteria. Roberts et al [19] were the first to apply TRPS to measure bacteria. They 
determined concentrations of marine photosynthetic cyanobacterium 
Prochlorococcus in the same experiment with Baculovirus. The results were 
comparable to those of microscopic analysis and flow cytometry. 
 
Yu and colleagues [76] have used TRPS for accurate and sensitive monitoring of 
bacterial growth. Using Bacillus subtilis and Escherichia coli, the researchers 
compared the sensitivity of detection of TRPS with the standard methods of bacterial 
growth detection, namely colony plating and optical density. Their results showed 
that TRPS is sensitive and accurate relative to the standard methods with a lower 
detection limit of 5x105 cells/ml. In addition, there was general agreement between 
TRPS and microscopy in cell volume measurements. The ability of TRPS to 
generate information about the concentration and the volume of the bacterial cell 
simultaneously may provide valuable information about the physical aspects of cell 
dynamics in real time.  
 
TRPS has also been applied for characterisation of bacteria in dairy products such 
as probiotics [77] and in environmental science [78-79]. In the study of Chung and 
co-workers [78], they used TRPS to measure the size distribution and surface 
charge of Francisella tularensis in their investigation of biofilm formation whereas 
Pang and colleagues [79] carried out comparative analysis of the size distribution 
and surface charge of biotin and glycoprotein coated microspheres to that of 
Cryptosporidium parvum oocytes in a bid to develop surrogate markers to quantify 
removal of the oocytes in porous media.  
 
Heider and Metzner [80], in their review of four modalities (TRPS, NTA, flow 
cytometry and field flow fractionation-multiple angle laser light scattering (FFF-
MALLS) for single virus particle analysis, have highlighted the advantages and 
disadvantages of these techniques. The authors noted that the TRPS determined 
virus particle concentration was several fold higher than the infectivity of the virus.    
 
 
TRPS in Nanotoxicology 
 
While nanopharmaceuticals offer great promise for targeted delivery of drugs and in 
theranostics, there are genuine concerns about their safety for in-vivo applications. 
Hence, it is paramount that detailed characterisation of nanoparticles are carried out 
to minimise any potential toxicity when they are introduced in to the human body. Pal 
and colleagues [81] investigated the utility of TRPS for characterisation of four 
different types of nanoparticles  (oxidised single walled carbon nanohorns, carbon 
black, cerium oxide and nickel nanoparticle) in cell culture media containing serum. 
The performance of TRPS was compared to that of DLS. Their results shown in 
figure 6 below, showed that although the size distribution obtained by the two 
techniques were comparable, TRPS offered higher resolution and sensitivity 
compared to DLS and unique insights into size distribution and concentration of the 
nanomaterials, as well as particle behavior and morphology in complex media 
 
 
Figure 6. Comparative evaluation of TRPS and DLS in characterizing sensitivity and stability of size 
distribution measurements of a series of sequential dilutions of SWCNH-ox in the range of 0.5–50 
μg/mL, prepared from a stock solution of 500 μg/mL in RPMI+10% FBS. The graphs represent 
averages of triplicate measurements. Note changes in the DLS size distributions below 5 μg/mL, 
especially left-side broadening of the peak and appearance of a smaller peak <50 nm, related to 
proteins in serum. At higher concentrations (50 μg/mL) the peak broadened to the right, In contrast to 
DLS, the TRPS size distribution remained fairly constant over the whole concentration range. 
Reprinted with permission from ACS Nano  2014, 8, 9003-9015. Copyright © 2014 American 
Chemical Society [ref] 
 
 
One of the methods by which nanopharmaceutical toxicity on blood cells such as 
erythrocytes, leucocytes and platelets could be studied is by analysing the 
membrane changes of that cell population. Since red cells are the most abundant 
cells in the body, toxicological studies of these cells may provide valuable 
information about the toxicity of the nanoparticle under investigation. Cheung et al 
[82] investigated the early apoptotic changes of erythrocytes, the so called 
'eryptosis', in response to a cytotoxic agent spolyphyllin D. The researchers studied 
the cell shrinkage and translocation of phosphatidylserine (PS) to the outer lipid 
bilayer of the plasma membrane, a hallmark of apoptosis, using microbeads 
functionalised with annexin-V for PS binding. The results of their study showed that 
this strategy of combining annexin-V beads and TRPS is a sensitive, reliable and 
simple technique to determine eryptosis of human erythrocytes for various 
biomedical applications.  
 
 
Conclusion and Future Perspective 
 
TRPS promises to be a valuable tool for nanoparticle characterisation. The ability of 
this technique to carry out particle by particle measurement of size and surface 
charge in addition to determining the concentration of polydisperse solutions and 
colloids makes it particularly useful for analysing nanopharmaceuticals. This 
technique permits studying nanoparticle behaviour in various biological fluids such 
as blood and plasma, in particular, the important phenomenon of protein corona 
formation.  In addition, this technique can also be used to study the pharmacological 
and toxicological effects of effects of nanopharmaceuticals on blood cells. This 
application may become useful in evaluating nanopharmaceuticals prior to various 
regulatory approval processes. 
 
In the rapidly expanding field of extracellular vesicle research, TRPS is proving a 
useful technique to size exosomes. An accurate determination of the size distribution 
of EVs may facilitate understanding of the biological and pathological role of these 
vesicles in physiology and in various disease states. It may also aid development of 
exosome based drug/gene delivery systems.  
 
TRPS also has a potential for the development of  a rapid  and low cost platform for 
quantification and characterisation of microbes including bacteria and viruses.  The 
ability of TRPS to perform tagless detection of subtle changes in the size, shape and 
surface charge may enable development of biosensors using organic/inorganic 
nanoparticles, DNA, aptamers and other nanomaterials to detect biological 
molecules for early diagnosis of diseases and to monitor therapeutic responses.  
 
This technique also has a potential in toxicological evaluation of nanoparticles by 
providing valuable information about the interactions between the nanoparticles and 
blood components such as proteins and cells.  This technique may, therefore, aid 
various regulatory authorities in evaluating nanopharmaceuticals for clinical 
applications. 
 
While the above mentioned potentials are recognised, it must also be emphasised 
that the technology of TRPS requires optimisation and standardisation to establish 
sensitivity, specificity and reproducibility. The manufacturers of the TRPS based 
devices and their users must conduct detailed, systematic and comparative 
evaluation of various technologies that are currently used for nanoparticle 
characterisation.   
 
   
 
 
 
 
Executive Summary 
 
Nanoparticle characterisation is an important pre-requisite for developing various 
nanodiagnostic platforms and, more importantly,  nanopharmaceuticals 
 
A diverse array of measurement modalities ranging from microscopy to diffraction 
techniques and spectroscopies are currently in use. No single technique can 
reliably be used to carry out the necessary measurements of different 
nanomaterials that are being studied for nanomedicine applications.  
 
Tunable Resistive Pulse Sensing (TRPS) is a recent addition to the  list of 
nanomaterial characterisation techniques. It is a variant of the established 
technique of Resistive Pulse Sensing (RPS) invented by Coulter in 1953. A size 
tunable elastomeric pore membrane is used to change the pore size and to improve 
detection sensitivity.  
 
One of the important features of TRPS is its ability to measure simultaneously the 
size and surface charge of individual nanoparticles. It is also capable of analysing 
polydispersed nanoparticle samples and colloids. 
 
This technology may provide a rapid and low cost platform to count and 
characterise bacteria and viruses. 
 
The ability of TRPS in detecting minute changes in the size, surface charge and 
shape permits development of sensitive biosensors by using nanomaterials such as 
organic/inorganic nanoparticles, DNA and aptamers.   
 
TRPS is proving a valuable tool in the rapidly expanding field of extracellular vesicle 
research by providing accurate information about the size distribution of exosomes 
that are generated in physiological and various pathological conditions including 
cancer and inflammatory diseases. 
 
The ability of TRPS to study the interactions between nanomaterials and blood 
components such as plasma proteins and cells may permit development of assay 
platforms to evaluate nanopharmaceuticals for clinical use.  
 
To realise the full potential of this technology, it needs optimisation and 
standardisation and also comparative analysis with other available technologies to 
precisely define its role in nanomedicine and nanotechnology. 
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